NASDAQ: SLGL - Sol-Gel Technologies Ltd.

Lønnsomhet i seks måneder: +21.83%
Utbytte: 0.00%
Sektor: Healthcare

Kampanjeplan Sol-Gel Technologies Ltd.

Avansert tidsplan Enkel graf
Financial Markets by TradingView

Om selskapet Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on identifying, developing, and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel.

flere detaljer
The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has completed Phase III clinical trials for the treatment of acne vulgaris; Epsolay, a once-daily topical cream that has completed Phase III clinical trials for the treatment of papulopustular rosacea; SGT-210, which is in Phase I clinical trial for the treatment of palmoplantar keratoderma; SGT-610, a rare disease for the treatment of Gorlin Syndrome which has completed Phase II clinical trials; and Erlotinib and Tapinarof to treat other rare skin indications. It is also involved in the development of generic topical dermatological drug products. The company has collaboration with Perrigo. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.
Legg til i sammenligningslisten
Legg til overvåkningsliste
Legg til portefølje
Legg til prisvarsel

IPO date 2018-01-23
ISIN IL0011417206
Industry Pharmaceuticals
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.sol-gel.com
Цена ао 0.9875
Prisendring per dag: -8.2% (1.22)
Prisendring per uke: +161.07% (0.429)
Prisendring per måned: +94.78% (0.575)
Prisendring over 3 måneder: +64.73% (0.6799)
Prisendring over seks måneder: +21.83% (0.9193)
Prisendring per år: +1.36% (1.105)
Prisendring over 3 år: -83.98% (6.99)
Prisendring over 5 år: -86.49% (8.29)
Prisendring over 10 år: 0% (1.12)
Prisendring siden begynnelsen av året: +109.74% (0.534)
Alle parametere

Undervurdering

Navn Betydning Karakter
P/S 20.92 1
P/BV 0.8411 9
P/E 0 0
EV/EBITDA -0.9182 0
Total: 4.63

Effektivitet

Navn Betydning Karakter
ROA, % -60.15 0
ROE, % -70.48 0
Total: 0

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0 0
Total: 0

Plikt

Navn Betydning Karakter
Debt/EBITDA -0.057 10
Total: 10

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % -93.21 0
Lønnsomhet Ebitda, % 15.39 3
Lønnsomhet EPS, % -20.18 0
Total: 1
Flere detaljer

Institusjoner Volum Dele, %
Phoenix Holdings Ltd. 2574922 9.24
Armistice Capital, LLC 2135000 7.66
Migdal Insurance & Financial Holdings Ltd. 1227548 4.41
Harel Insurance Investments & Financial Services Ltd. 920333 3.3
Kingdon Capital Management LLC 674923 2.42
Yelin Lapidot Holdings Management Ltd. 229178 0.82
Raymond James Financial Services Advisors, Inc. 43102 0.15
Raymond James & Associates, Inc. 30915 0.11
Morgan Stanley 28935 0.1
Citadel Advisors Llc 17259 0.06



Veileder Stillingstittel Betaling Fødselsår
Dr. Alon Seri-Levy Co-Founder, CEO & Director 411k 1961 (64 år)
Mr. Gilad Mamlok Advisor 367k 1968 (57 år)
Dr. Itzik Yosef Chief Operating Officer 236k 1976 (49 år)
Mr. Moshe Arkin Executive Chairman of the Board N/A 1953 (72 år)
Prof. David Avnir Co-Founder N/A
Ms. Tamar Fishman Jutkowitz VP & General Counsel N/A 1976 (49 år)
Dr. Karine Neimann VP of Projects & Planning and Chief Chemist N/A 1971 (54 år)
Mr. Eyal Ben-Or Chief Financial Officer

Adresse: Israel, Ness Ziona, 7 Golda Meir Street - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.sol-gel.com